PortfoliosLab logoPortfoliosLab logo
9926.HK vs. 2269.HK
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

9926.HK vs. 2269.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a HK$10,000 investment in Akeso Inc (9926.HK) and WuXi Biologics (2269.HK). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

9926.HK vs. 2269.HK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
9926.HK
Akeso Inc
24.34%86.31%30.71%7.91%26.47%-10.53%56.38%
2269.HK
WuXi Biologics
11.26%78.64%-40.54%-50.54%-35.33%-9.26%165.16%

Returns By Period

In the year-to-date period, 9926.HK achieves a 24.34% return, which is significantly higher than 2269.HK's 11.26% return.


9926.HK

1D
0.93%
1M
41.14%
YTD
24.34%
6M
0.50%
1Y
59.66%
3Y*
52.58%
5Y*
21.21%
10Y*

2269.HK

1D
0.34%
1M
-5.46%
YTD
11.26%
6M
-16.87%
1Y
33.26%
3Y*
-9.57%
5Y*
-19.75%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

9926.HK vs. 2269.HK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

9926.HK
9926.HK Risk / Return Rank: 7171
Overall Rank
9926.HK Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
9926.HK Sortino Ratio Rank: 6868
Sortino Ratio Rank
9926.HK Omega Ratio Rank: 6767
Omega Ratio Rank
9926.HK Calmar Ratio Rank: 7979
Calmar Ratio Rank
9926.HK Martin Ratio Rank: 7272
Martin Ratio Rank

2269.HK
2269.HK Risk / Return Rank: 6060
Overall Rank
2269.HK Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
2269.HK Sortino Ratio Rank: 5757
Sortino Ratio Rank
2269.HK Omega Ratio Rank: 5858
Omega Ratio Rank
2269.HK Calmar Ratio Rank: 6161
Calmar Ratio Rank
2269.HK Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

9926.HK vs. 2269.HK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Akeso Inc (9926.HK) and WuXi Biologics (2269.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


9926.HK2269.HKDifference

Sharpe ratio

Return per unit of total volatility

0.94

0.63

+0.31

Sortino ratio

Return per unit of downside risk

1.55

1.12

+0.44

Omega ratio

Gain probability vs. loss probability

1.21

1.16

+0.05

Calmar ratio

Return relative to maximum drawdown

2.46

0.98

+1.48

Martin ratio

Return relative to average drawdown

4.38

2.38

+2.00

9926.HK vs. 2269.HK - Sharpe Ratio Comparison

The current 9926.HK Sharpe Ratio is 0.94, which is higher than the 2269.HK Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of 9926.HK and 2269.HK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


9926.HK2269.HKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.94

0.63

+0.31

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.31

-0.30

+0.61

Sharpe Ratio (All Time)

Calculated using the full available price history

0.51

0.27

+0.24

Correlation

The correlation between 9926.HK and 2269.HK is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Dividends

9926.HK vs. 2269.HK - Dividend Comparison

Neither 9926.HK nor 2269.HK has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

9926.HK vs. 2269.HK - Drawdown Comparison

The maximum 9926.HK drawdown since its inception was -82.37%, smaller than the maximum 2269.HK drawdown of -92.95%. Use the drawdown chart below to compare losses from any high point for 9926.HK and 2269.HK.


Loading graphics...

Drawdown Indicators


9926.HK2269.HKDifference

Max Drawdown

Largest peak-to-trough decline

-82.37%

-92.95%

+10.58%

Max Drawdown (1Y)

Largest decline over 1 year

-46.13%

-28.29%

-17.84%

Max Drawdown (5Y)

Largest decline over 5 years

-82.37%

-92.95%

+10.58%

Current Drawdown

Current decline from peak

-20.58%

-75.98%

+55.40%

Average Drawdown

Average peak-to-trough decline

-32.86%

-42.31%

+9.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.95%

14.73%

+11.22%

Volatility

9926.HK vs. 2269.HK - Volatility Comparison

Akeso Inc (9926.HK) has a higher volatility of 18.27% compared to WuXi Biologics (2269.HK) at 14.41%. This indicates that 9926.HK's price experiences larger fluctuations and is considered to be riskier than 2269.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


9926.HK2269.HKDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.27%

14.41%

+3.86%

Volatility (6M)

Calculated over the trailing 6-month period

36.44%

31.76%

+4.68%

Volatility (1Y)

Calculated over the trailing 1-year period

65.63%

54.68%

+10.95%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

70.19%

66.79%

+3.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

69.47%

60.32%

+9.15%

Financials

9926.HK vs. 2269.HK - Financials Comparison

This section allows you to compare key financial metrics between Akeso Inc and WuXi Biologics. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in HKD except per share items